Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies. 

Biotechnology

Education

Genesis Therapeutics

Genesis Therapeutics' headquarters in South San Francisco, CA, United States

This department focuses on scientific research and innovation to advance product development and enhance technological capabilities.

Research and Development

The Biology & Chemistry Team at Genesis Therapeutics spearheads the discovery and optimization of novel small molecule drugs. Leveraging cutting-edge molecular AI technology, the team conducts rigorous biological and chemical research, including medicinal chemistry, drug metabolism and pharmacokinetics (DMPK), and immunology. Their expertise is critical to advancing treatment options for severe and debilitating diseases, ensuring that drug candidates are scientifically validated and clinically promising.

Biology & Chemistry Team

The Machine Learning and AI Team at Genesis Therapeutics leverages advanced machine learning algorithms and artificial intelligence to accelerate the discovery and development of novel small molecule drugs. This team focuses on creating predictive models and computational tools to optimize molecular design, streamline drug development processes, and enhance clinical outcomes for patients with severe diseases.

Machine Learning and AI Team

This department focuses on advancing machine learning methodologies and developing innovative algorithms and models.

Machine Learning Research

This department focuses on designing, developing, and maintaining software applications and systems.

Software Development

The Leadership Team at Genesis Therapeutics is responsible for setting the strategic direction of the company, overseeing the development of innovative drug candidates, and ensuring effective collaboration across all departments. Comprising experienced leaders in biotechnology, the team drives both internal and partnership initiatives to harness molecular AI technology, ultimately aiming to transform clinical outcomes for patients with severe diseases.

People (6)

Jobs (0)

Other teams

Biology & Chemistry Team

Machine Learning and AI Team

Machine Learning Research

Software Development

Leadership Team